Wellell Inc (4106) Fair Value & Analysis
Healthcare · TW · Market cap 2.4B TWD
Fair value as of: Jun 24, 2026
Analysis
Wellell Inc (4106) currently trades at 23.10 TWD, while our model-based Fair Value estimate is 26.41 TWD — implying the stock looks roughly 14.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Wellell Inc. engages in the manufacture and sale of medical supplies in Europe, the United States, Asia, and internationally. The company offers support surface systems, respiratory therapy devices, and other products. It also provides pressure relief mattress; sleep apnea such as auto-adjusting pressure; sleepwell; compression therapy; and pressure relief seating products. In addition, the company offers pressure injury prevention, and obstructive sleep apnea solutions. The company was founded in 1990 and is based in New Taipei City, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Wellell Inc (4106) undervalued?
What is the fair value of 4106?
What is the quality score of 4106?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.